SCHEMBL13730047

SCHEMBL13730047

Nc1nccc(-c2cccc(OC(F)(F)F)c2)c1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.51
▸ ADORA2A P29274 1/20 0.51
▸ XDH P47989 1/20 0.46
▸ DYRK1A Q13627 6/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ SCN10A Q9Y5Y9 1/20 0.45
▸ NPY5R Q15761 1/20 0.44
▸ ATR Q13535 1/20 0.44
▸ GRM5 P41594 1/20 0.43
▸ BTK Q06187 1/20 0.43
▸ CTSD P07339 1/20 0.42
▸ BACE1 P56817 1/20 0.42
▸ BACE2 Q9Y5Z0 1/20 0.42
▸ PDE4A P27815 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ SCN9A Q15858 2/20 0.40
▸ DHFR P00374 1/20 0.40
▸ CCNT1 O60563 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4938505 0.81 DYRK1A (0.54) ADORA1ADORA2ADYRK1A
SCHEMBL1389085 0.76 DHFR (0.59) ADORA1ADORA2AXDHDYRK1AKCNH2
SCHEMBL29655604 0.76 DHFR (0.59) ADORA1ADORA2AXDHDYRK1AKCNH2
SCHEMBL30046490 0.76 KDM4E (0.54) ADORA1ADORA2AXDHDYRK1AKCNH2
SCHEMBL17555726 0.75 FYN (0.49) CCNT1CDK9
SCHEMBL30681801 0.74 GRM5 (0.49) ADORA1ADORA2AXDHDYRK1AKCNH2
SCHEMBL399198 0.74 ADORA1 (0.53) ADORA1ADORA2AXDHDYRK1AKCNH2
SCHEMBL8103598 0.73 DYRK1A (0.61) XDHDYRK1AKCNH2SCN10ANPY5R
SCHEMBL12100759 0.73 MAP4K4 (0.46) ADORA2A
SCHEMBL12127278 0.73 NUDT1 (0.60) DYRK1ANPY5RCCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012146667-A1 IMIDAZOPYRIDINE DERIVATIVES AS PI3K INHIBITORS ALMIRALL, S.A. (ES) 2012-11-01 — — WO disclosed
Send feedback